Cognitive Rehabilitation for Traumatic Brain Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help Veterans with a history of mild to moderate traumatic brain injury (TBI) improve attention, memory, and emotional control, which are vital for success in daily life. It will test two remote rehabilitation approaches—BrainStrong-GSR and BrainStrong-OPT—delivered via tele-rehabilitation and supported by digital apps. Veterans who have had a TBI, experience issues like trouble with working memory, and are interested in setting personal goals and intensive training might be a good fit. This unphased trial offers Veterans the opportunity to explore innovative rehabilitation methods tailored to their needs.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that participants should not have active changes in psychotropic medications (drugs affecting mood, perception, or behavior). It's best to discuss your specific medications with the trial coordinators.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have examined the treatments BrainStrong-GSR and BrainStrong-OPT for aiding individuals with traumatic brain injury (TBI). These treatments aim to enhance skills such as attention and memory. Research has shown that both treatments are designed to be safe and manageable.
For BrainStrong-GSR, studies have not identified any major safety concerns. This treatment improves focus and task completion. Although specific side effects are not detailed, the absence of reported issues suggests it is likely well-tolerated.
Similarly, BrainStrong-OPT seeks to enhance brain function. While research on brain injury has tested various methods, no specific evidence indicates harmful effects from BrainStrong-OPT itself. This implies it may be safe to use, though detailed safety information remains limited.
With the trial phase marked as "Not Applicable," these treatments might be considered non-invasive or low-risk. This generally indicates they are expected to be safe, but consulting a healthcare provider is essential to understand any personal risks.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because BrainStrong-GSR and BrainStrong-OPT offer new approaches to cognitive rehabilitation for traumatic brain injury (TBI). Unlike traditional therapies like cognitive behavioral therapy or medication, BrainStrong-GSR uses Goal-directed State Regulation Training, which focuses on helping patients control their cognitive states. Meanwhile, BrainStrong-OPT aims to enhance brain functioning by optimizing neural pathways. These methods provide innovative ways to tackle TBI symptoms, potentially offering more personalized and effective rehabilitation options.
What evidence suggests that this trial's treatments could be effective for traumatic brain injury?
Research has shown that after a traumatic brain injury (TBI), the brain can heal by forming new connections, a process called neuroplasticity. In this trial, participants will join one of two treatment arms. The BrainStrong-GSR method, one treatment being tested, focuses on improving metacognitive skills, helping individuals think about their own thinking. Studies have found that this can lead to better outcomes in daily life for those with TBI. Meanwhile, the BrainStrong-OPT method, another treatment option in this trial, may enhance brain function by addressing heart-related issues linked to the severity of TBI. Both methods aim to improve goal-directed activities, which are essential for enhancing quality of life after a TBI.16789
Who Is on the Research Team?
Anthony J. W. Chen, MD MA
Principal Investigator
VA Northern California Health Care System, Mather, CA
Are You a Good Fit for This Trial?
This trial is for post-9/11 Veterans aged 21-60 who have had a mild to moderate traumatic brain injury and are at least six months into recovery. They should experience cognitive symptoms like memory issues and be interested in goal-setting and training. It's not suitable for those with severe mental health conditions, other neurological disorders, or ongoing medical issues that could affect participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Goal-directed State Regulation Training (GSR) or Optimization of Brain Functioning (OPT) via tele-rehabilitation, augmented by digital apps
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3 months post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- BrainStrong-GSR
- BrainStrong-OPT
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor